Cysteamine in Cystic Fibrosis

Update Il y a 4 ans
Reference: EUCTR2014-000284-40

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

The primary objective of this study is to characterise the blood pharmacokinetic profile of oral immediate-release cysteamine (Cystagon) when administered to patients with Cystic Fibrosis at the dose licensed for use in cystinosis.


Inclusion criteria

  • Cystic fibrosis

Links